# 41 - Symptom Tracker Readiness Review
## Version 1.0 — 2026-07-03

> Pre-implementation review for **Batch PA-4** (docs/29 §13 Batch 5E: the `SymptomLogs`
> sheet and the patient-facing Symptom Tracker — the first patient-*writable* Phase 2A
> feature, per docs/29 §9). Per this session's explicit instruction: **no code was
> written to produce this review**, no production code, shared contract, schema, Apps
> Script file, or frontend file was created or modified — everything below is scoped
> strictly to the already-approved docs/29 §9 (Symptom Tracker v1 Architecture), docs/21
> ("Symptom Tracker" — Patient variant), docs/23 (Patient Lifecycle), and docs/33 §3.2
> (Symptom Log). This document does not authorize PA-4 to begin; implementation waits
> for separate approval, the same discipline docs/37 and docs/39 were held to before
> PA-2 and PA-3.
>
> **PA-3 status:** per this session's instruction, Batch PA-3 (docs/29 §13 Batch 5D) is
> now **frozen except for bug fixes**, joining Foundation, Identity & Access, and PA-1/PA-2
> as stable, tested surface. Nothing in this review modifies or depends on changing any
> PA-3 file.

---

# 1. Symptom Lifecycle

Per docs/33 §3.2 (already approved, not a new decision): **create → persist → read.
No update. No delete. No review/approval gate.**

- **Created** by the patient, at will, through the authenticated dashboard — the *only*
  entity in the entire domain model a patient writes directly (docs/29 §9, docs/33 §3.2).
  Unlike Consultation Summary or a future Doctor Instruction, there is no AI-Summary-
  pattern gate (ADR-005) here, because a Symptom Log is a raw patient self-report, not
  clinical content generated on the patient's behalf — ADR-005's gate governs
  AI-generated, patient-facing artifacts, and nothing here is AI-generated.
- **Persisted** permanently. docs/33 §3.2: "never edited or deleted by the patient once
  submitted — an honest, permanent self-report, consistent with an audit-style health
  record, not a mutable journal." Retained indefinitely, subject to whatever future
  "patient data belongs to the patient" mechanism (docs/30 §3) is eventually built —
  not a mechanism this batch needs to build.
- **Read** by the patient (own history only) and viewable, never alterable, by
  staff/doctor (docs/33 §3.2 Ownership: "staff/doctor can view but not alter a patient's
  own entries — the health record belongs to the patient, not staff, for this one
  entity").
- **Consumed later** by Digital Twin's symptom-trend view (Phase 2D, docs/33 §3.2 Future
  evolution) — "no schema change anticipated, only a new consumer." Nothing in PA-4
  should anticipate that consumer's needs beyond storing clean, typed data.

This is the simplest lifecycle of any entity in the domain model specifically because it
carries no doctor-review step — a deliberate, already-approved property, not an omission
this review should question.

---

# 2. Symptom Information Architecture

Two levels, not three — narrower than Timeline's three-level drill-down (docs/39 §1),
and deliberately so:

1. **Dashboard card** (docs/29 §5: "Symptom Tracker card — quick-log control + link to
   full history"). This card is unusual among the six dashboard cards: it is the only
   one whose primary content is a **write** affordance, not a read preview. It should
   show a small quick-log form (or a clear entry point into one) plus, once entries
   exist, a bare most-recent-value summary — not a chart, not a trend line (§9 below).
2. **Full history page** (new, this batch) — the patient's own chronological log,
   reverse order, capped for payload size (mirroring docs/29 §6's Timeline cap
   precedent). docs/29 §9 is explicit: "at most a bare recent-value list."

**No third, per-entry detail level is needed**, unlike Consultation History (docs/39 §1
level 3). A Symptom Log row is a handful of 1–10 scale values plus a short optional
note — there is no long-form text that benefits from its own page the way a full
`summary_text` does. Building a detail view here would be inventing a fourth thing
docs/29 §9 doesn't ask for, the same "don't invent a level" discipline docs/39 §1 already
applied to Timeline. If a later phase adds richer per-entry content, a detail view can be
added then — not speculatively now.

---

# 3. Draft vs. Submitted Entries

**No persisted draft state exists in the approved architecture, and none should be
introduced without an explicit decision.** docs/29 §9 describes a single-step flow:
"Simple form... → POST → row in `SymptomLogs`." docs/33 §3.2 reinforces this: an entry
is "logged by the patient" and immediately becomes the permanent, non-editable record
(§1 above) — there is no intermediate `pending`/`draft` status field anywhere in docs/29
§4's `SymptomLogs` column list or docs/33 §3.2's attribute list, unlike Consultation
Summary's `review_status` staging.

**This review's finding:** the only correct reading of currently-approved architecture
is that "draft" can mean nothing more than **unsaved, client-side form state** — values
sitting in input fields before the patient presses submit, never persisted, lost on
navigation away, exactly like `login.html`'s email field before its own submit. A
server-persisted, resumable draft (e.g., "save and finish later") is a **new capability**
that would require a schema field (e.g., a `status` column) docs/29 §9 does not define
and docs/33 §3.2 does not model.

**Recommendation, not a decision made here:** treat PA-4 as having no persisted draft
state — a single atomic client-fill-then-submit form, consistent with every other
Phase 2A form built so far (`login.html`, `verify.html`'s implicit one-shot actions).
If persisted drafts are wanted, that is a scope addition needing its own explicit
approval before PA-4's schema is written, not something to infer from silence.

---

# 4. Editing Rules

**Already settled, not open for this review to decide.** docs/33 §3.2: "never edited...
once submitted." No update endpoint should exist for `SymptomLogs`, for the patient or
for staff. This mirrors the "doctors decide" pattern (docs/30 §2) but in the opposite
direction from Consultation History — there, the patient can't edit because *staff*
own the content; here, the patient can't edit because the record's value **is** that it
is an honest, timestamped self-report, and allowing edits after the fact would undermine
that property for both the patient's own trend-reading and any future clinical review.

If a patient makes a data-entry mistake, the correct pattern (not yet needed until this
is a real product question) is a new corrective entry, not a mutation of the old one —
the same "audit trail, never rewritten" discipline Consultation Summary's Batch 4F
retention purge already respects for its own record.

---

# 5. Deletion Rules

**Also already settled.** Same docs/33 §3.2 sentence covers both: "never edited or
deleted by the patient once submitted." No delete endpoint, patient- or staff-facing.
Retention is indefinite, deferred to docs/30 §3's still-unbuilt "patient data belongs to
the patient" mechanism — explicitly **not** this batch's problem to solve, the same way
docs/29 §4 already states for the platform generally ("no export/deletion mechanism is
built in this phase, but no schema decision here should make one harder to add later").

`SymptomLogs` rows should be flat and patient_id-keyed (ADR-006 discipline, unchanged)
specifically so a future deletion/export mechanism can operate on them without a
migration — nothing more is required of PA-4 on this point.

---

# 6. Relationship to Consultations

**Independent, by design — no foreign key to Consultation or Consultation Summary.**
docs/29 §4's `SymptomLogs` columns (`record_id`, `patient_id`, `logged_at`, `severity`,
`sleep`, `energy`, `stress`, `notes`, `condition_slug`) include no `consultation_id` or
`source_ref`-style pointer, unlike `ConsultationHistory`. The only shared vocabulary is
`condition_slug`, reusing the same canonical taxonomy every other entity already uses
(docs/20 §5, "the slug is the ID") — a shared tag, not a relationship.

This is a deliberate asymmetry: Consultation History is doctor-authored and visit-bound;
Symptom Log is patient-authored and continuous, logged whenever the patient chooses,
independent of whether a consultation happened that day. PA-4 should not add a
consultation link — doing so would be an unrequested schema addition, not a
clarification of existing scope.

---

# 7. Relationship to Timeline

**Excluded from the Timeline feed in this batch — already decided, carried forward
unchanged from docs/39 §8.** docs/29 §6 scopes Timeline strictly to `ConsultationHistory`;
docs/33 §3.1 lists Symptom Log feeding Timeline Event only as a "future extension, not
current scope"; docs/39 §8 states plainly: "PA-3 should not pull `SymptomLogs` into the
Timeline query — doing so would be scope creep." The same sentence applies verbatim to
PA-4, in the reverse direction: **PA-4 should not add Symptom Log rows into the Timeline
query either.** The Symptom Tracker keeps its own separate dashboard card and its own
full-history page until a later, explicitly-planned batch deliberately merges the two
feeds (the natural point being once `entry_type` — docs/33 §3.1, closed for
`"consultation"` in PA-3 — is deliberately widened, which docs/39 §2 and this document
both say should happen only when a second source is actually built, not in anticipation).

---

# 8. Relationship to Digital Twin

**Future-only, unmodified by this batch.** docs/33 §3.2 Future evolution: Symptom Log is
"the natural first data source for Digital Twin's 'symptom trends' (docs/09) once Phase
2D exists — no schema change anticipated, only a new consumer." Digital Twin itself
(docs/33 §3.5) is a computed, read-only aggregate view — never a base table — bound
permanently by ADR-004 (never diagnosis or treatment) and gated by the full
ADR-001/ADR-004/ADR-005 pattern, entirely out of Phase 2A's scope (docs/29 §2.2, docs/24
Phase 2D). PA-4's only obligation toward this future relationship is to store clean,
typed, consistently-shaped data (flat columns, stable `record_id`, ADR-006) so a future
Digital Twin consumer can read it without a migration — nothing about trend computation,
visualization, or AI narration belongs in this batch.

---

# 9. Relationship to AI

**Categorically excluded, repeated explicitly in three separate places in the approved
architecture, and this review adds no fourth interpretation.** docs/29 §0: "No AI is used
anywhere in this phase." docs/29 §9: "Deliberately no trend analysis, no AI commentary,
no insights... must not creep in here." docs/29 §11 risk #8 names this exact scope-creep
risk explicitly, tying it to ADR-001/004/005's phase boundary. Symptom Tracker v1 is pure
data capture and pure data display — a number in, the same number back out, nothing
computed or generated in between.

**A minor documentation inconsistency, found while reading this section, not blocking:**
docs/29 §9's own sentence attributes "Digital Twin/Progress Analytics territory" to
"Phase 2C" — but docs/29's own Roadmap section (and docs/24-ROADMAP.md, and docs/33 §3.5)
consistently assign Digital Twin/AI Summaries/Progress Analytics to **Phase 2D**, with
Phase 2C reserved for the non-AI Health Milestones work specifically "separated from
Phase 2D's AI-supervised work." §9's phase label is a stale reference, not a substantive
disagreement — every other mention of this boundary agrees on 2D. Recorded under
Repository Consistency Review below as a documentation-only fix, not a blocker.

---

# 10. Validation Rules

docs/29 §9: "Simple form (1–10 scale inputs + optional free-text note + optional
`condition_slug` tag)." Applying the same "server validates, client is UX only"
discipline docs/29 §8 already states for Report Upload:

- **`severity`, `sleep`, `energy`, `stress`** — integers on a 1–10 scale, validated
  server-side regardless of what a client-side slider/stepper enforces.
- **`notes`** — optional free text; must be HTML-escaped before storage/render using the
  same `escapeFoundationHtml_()`/`escapeHtmlForDisplay()`-style helper every other
  patient-facing free-text field already uses (docs/29 §14 F2, PA-3's
  `escapeHtmlForDisplay()`) — never trusted as markup.
- **`condition_slug`** — optional; if present, should reuse the canonical
  `ALLOWED_CONDITION_SLUGS` taxonomy (docs/20 §5). Note this validation was explicitly
  and openly deferred for `Patients.condition_slug` in Batch F3 ("duplicating that list
  now, with no second real consumer beyond a copy-paste, was already flagged as
  premature... `shared/constants/` is exactly where this belongs once it's needed for
  real"). **PA-4 is that trigger point** — `SymptomLogs.condition_slug` would be a real
  second consumer of the same list, alongside `Patients.condition_slug`. Recommend this
  batch finally populate `shared/constants/` with the canonical slug list, closing F3's
  named deferral, rather than deferring a third time or duplicating the list again.
- **`patient_id`** — always session-derived (ADR-002, unchanged), never accepted from
  the request body, identical to every existing Foundation route.
- **`logged_at`** — server-set at write time by default (`foundationNowIso_()`),
  consistent with every other `created_at`-style field's provenance discipline.

**Open question this review surfaces rather than assumes an answer to:**
1. Are all four scale fields (`severity`/`sleep`/`energy`/`stress`) mandatory per entry,
   or can a patient submit a partial log (e.g., severity only)? Neither docs/29 §9 nor
   docs/33 §3.2 states this explicitly.
2. Should `logged_at` ever be patient-editable (e.g., "log for earlier today" or a
   specific past date), the way Consultation History's `entry_date` intentionally
   diverges from `created_at` (docs/39 §3)? No equivalent distinction is defined for
   Symptom Log today — the safe default is "always now, not patient-selectable," but
   this should be confirmed, not assumed, since it affects both the schema and the sort
   behavior of the full-history view.

Neither question blocks this review; both should be resolved before the
`shared/schemas/symptom-log.schema.json` contract is written (§12 below), the same way
docs/37 listed open UX questions without those questions blocking the review itself.

---

# 11. Offline Behavior

**No offline/PWA architecture exists anywhere in this repository — this is a genuine
gap, not a settled decision this review can just apply.** A repository-wide search found
zero mentions of offline support, service workers, or a Progressive Web App pattern in
any product, architecture, or standards document (docs/00 through docs/40, `/adr/`,
docs/10-DEVELOPMENT-STANDARDS.md's "Technology Stack," or docs/16-PERFORMANCE-STANDARDS.md).
Every existing Phase 2A page (`login.html`, `verify.html`, the dashboard, the Timeline
pages) already assumes a live network round trip for every authenticated action — there
is no existing offline-queue, local-cache, or background-sync precedent to extend.

**Per this session's instruction to stop and explain rather than assume:** this review
does not invent an offline design. The conservative, consistent-with-everything-already-
built default is **no offline support in PA-4** — the quick-log form requires a live
connection to submit, exactly like every other Foundation write path today, and should
fail with the same friendly, non-technical network-error message (docs/04 Error State)
`dashboard.js`'s existing network-failure handling already uses, preserving the
in-progress form values so the patient isn't asked to re-type them, rather than silently
queuing a request to send later. If offline capture (e.g., logging a symptom during a
connectivity gap and syncing once reconnected) is actually wanted for Symptom Tracker
specifically, that is a materially different engineering commitment — a sync/conflict
model, local storage of unsent health data, a retry queue — that does not exist in any
approved plan and should be an explicit, separate decision before PA-4 begins, not
something inferred from the product vision's general "continuous care" language.

---

# 12. Backend Contracts Required

Named here as requirements this review identifies — **not designed or implemented by
this document**, following docs/39 §10's own framing exactly. Per docs/29 §14 Decision
1's established pattern (a new, distinctly-named entity file added to the existing
`apps-script/` project, never modifying frozen files):

- A new `shared/schemas/symptom-log.schema.json` (+ `.md`), mirroring the existing
  `shared/schemas/*.schema.json` pattern — resolving §10's two open questions
  (required/optional fields, `logged_at` semantics) before this contract is written.
- A new Foundation entity file (e.g. `FoundationSymptomLog.gs`) providing:
  - A patient-facing, session-authenticated **create** function — `patient_id` derived
    from the verified session only, exactly like every existing write/read path
    (ADR-002, unchanged).
  - A patient-facing, session-authenticated **list** function returning the caller's own
    entries, capped and sorted (`logged_at` descending, mirroring docs/39 §3's
    tiebreaker discipline if two entries share a timestamp).
- **A structurally simpler authorization surface than PA-3 needed, worth noting
  explicitly.** docs/40's "record-ownership verification for a client-supplied
  identifier" was necessary for Consultation History because a patient could request
  another patient's `record_id` directly. Per §2 above, Symptom Tracker v1 needs **no
  per-entry detail fetch by `record_id`** — only create-own and list-own — so unless a
  future batch adds a single-entry view, `FoundationSymptomLog.gs` does not need an
  equivalent to `foundationGetConsultationEntryById_()`. This should be treated as a
  simplification to confirm, not a gap to fill by building a detail-fetch function
  nothing in docs/29 §9 asks for.
- Two new `FoundationRouter.gs` dispatch cases (e.g. `log_symptom`, `get_symptom_logs`),
  following `get_profile`/`get_timeline`'s existing thin-wiring precedent — the same
  category of additive, disclosed exception PA-3 already used for its own two new cases.
- A new conformance stage in `validation/phase-2a-foundation/conformance.js`, covering —
  at minimum — cross-patient isolation on both create and list (the single highest-risk
  property for the platform's first patient-*writable* endpoint, per docs/29 §11's own
  risk framing for why 5E is sequenced before 5F's file-upload risk).

---

# 13. Accessibility

WCAG 2.2 AA (docs/14), applied to this batch's two new surfaces — a **multi-field form**
(new territory: every Phase 2A form so far, `login.html`, has had exactly one field) and
a **read-only history list** (which should reuse PA-3's already-adapted list pattern
rather than invent a third one):

- Every scale field needs a real, associated `<label for>` — not a placeholder alone.
  If severity/sleep/energy/stress are implemented as range sliders, a bare slider with no
  visible or announced numeric value is a common, real accessibility gap; the control
  needs either a paired visible numeric readout or an accessible-name/value announcement
  a screen reader actually exposes, not decoration only.
- Carry forward the corrected `:focus-visible` handling from `login.html`/`verify.html` —
  **not** the still-unfixed `internal/consultation-summary.html` pattern (docs/37 §8's
  explicit warning, still applicable to any new form built by copying an existing one).
- The optional notes field, if a `<textarea>`, needs any character-limit feedback (if
  §10's validation adds one) surfaced as visible, non-color-only text.
- Submission feedback (success/error after posting a log) is genuinely new territory for
  this phase — every prior Phase 2A form (`login.html`/`verify.html`) either navigates
  away or is a single action per page load. A patient submitting a log and remaining on
  the same dashboard card needs an `aria-live` status region so the confirmation or error
  is announced without relying on sighted re-reading of the page — confirm whether the
  existing `.status` component already carries this, or needs it added, before reusing it
  here for the first time in this exact pattern.
- The full-history list should be a real ordered list (`<ol>`), mirroring docs/39 §11's
  rule for Timeline — chronological order is meaningful content here too.
- The "No entries yet" Empty State must remain in the accessible tree as plain text
  (docs/39 §4's rule, applied identically here).
- Loading skeletons should follow the existing `aria-busy`/skeleton-then-swap convention,
  not a new one.

---

# 14. Component Reuse

- **Fully reusable, unchanged:** `assets/site.css` tokens, `.card`/`.status`/`.skeleton`,
  and PA-2's Empty State component — the "No data yet" variant gets its second real
  consumer here (Timeline was its first, PA-3).
- **Reusable with adaptation:** `login.html`'s `.field`/`.submit` form components —
  extended, for the first time in Phase 2A, into a genuinely multi-field authenticated
  form. The base input/label/status pieces carry over; the layout (grouping four scale
  inputs plus a notes field) is new.
- **Directly reusable, not rebuilt a fourth time:** `my-health-journey/session-guard.js`
  (introduced PA-3 specifically so a third and later authenticated page wouldn't
  reimplement `dashboard.js`'s own session-guard IIFE) — the Symptom Tracker's full-
  history page is exactly the next consumer that recommendation anticipated.
- **Reusable with adaptation:** PA-3's `.tl-track`/`.tl-item` list visual, adapted for
  Timeline from the public site's `.journey`/`.j-step` pattern — the Symptom Tracker's
  full-history list is the same underlying shape (a reverse-chronological list of dated
  entries) and should reuse this pattern rather than invent a third list style for what
  is, structurally, the same kind of list.
- **Dashboard wiring pattern:** `dashboard.js`'s PA-3 addition (`loadTimelinePreview()` /
  `timelinePreviewHtml()`) is the template to mirror for a new
  `loadSymptomPreview()`-style pair — the same additive-only, disclosed-exception
  pattern to a frozen file, not a restructure of the shell.

---

# 15. Recommended Implementation Sequence

1. **Resolve open questions** (§10's required/optional fields and `logged_at`
   semantics; §11's offline scope) — needed before the schema is written, not
   discoverable from silence.
2. **Backend contracts** (§12): `shared/schemas/symptom-log.schema.json`,
   `FoundationSymptomLog.gs` (create + patient-scoped list only — no `get_by_id` unless
   a detail view is separately approved), `FoundationRouter.gs` wiring, a new
   conformance stage. Populate `shared/constants/` with the canonical condition-slug
   list as part of this step (§10), closing Batch F3's own named deferral.
3. **Quick-log form** — the dashboard card's write affordance, built and verified in
   isolation before wiring into the live card, mirroring docs/37 §9's "session guard
   before any card" sequencing applied to a form instead of a read path.
4. **Full history page** — reusing PA-3's `.tl-track`/`.tl-item` pattern and
   `session-guard.js` unchanged.
5. **Dashboard card update** — replace the "Coming later in Phase 2A" Empty State with
   the quick-log control plus most-recent-value summary plus "View full history" link,
   mirroring PA-3's Timeline-card wiring pattern (an additive, disclosed change to
   `dashboard.js`, not a restructure).
6. **Validation** — the new conformance stage above, plus a new committed browser-test
   suite (e.g. `validation/pa-4-symptom-tracker/`, mirroring `pa-3-timeline`'s
   discipline) explicitly covering the write path's cross-patient isolation — the
   platform's first patient-writable endpoint, and per docs/29 §11 the reason 5E is
   sequenced before 5F's higher-risk file upload: proving the write-authorization
   pattern here first.
7. **Documentation** — docs/04 (concrete Symptom Tracker component entries), docs/29
   §13/§16 (PA-4 implementation notes), docs/24 (roadmap), docs/33 (Symptom Log's
   `*Planned*` label updated to `*Implemented*`), CHANGELOG. While in docs/33, consider
   closing the stale `*Planned*` labels this review's Repository Consistency section
   below identifies (Patient/Patient Identity/Session, and the Timeline Event Summary
   Table row) in the same pass, per docs/39 Finding 2's own recommendation to batch
   these rather than fix one per closeout.
8. **Security note carried forward, not repeated in full:** this is the first
   patient-*writable* Phase 2A feature. docs/29 §11 sequenced it deliberately before
   Report Upload specifically so the write-authorization pattern is proven on
   lower-risk, non-file data first — the same "prove the pattern on the easy case
   first" discipline that already governed read-only Timeline before this batch.

---

# Repository Consistency Review

A scoped pass across the documents this batch touches or depends on — not a full
re-run of docs/34-ARCHITECTURE-CONSISTENCY-REVIEW.md's whole-repository sweep, which
remains the historical record of what it found. Mirrors docs/39's own scoping: this
checks only what has changed or become newly relevant since PA-3 shipped, plus what
this review itself touches.

**Finding 1 — docs/29 §9's "Phase 2C" reference to Digital Twin/Progress Analytics is
stale (real, minor, non-blocking).** Detailed in §9 above. Every other mention of this
boundary (docs/29's own Roadmap section, docs/24-ROADMAP.md, docs/33 §3.5) consistently
assigns Digital Twin/AI Summaries/Progress Analytics to Phase 2D and Health Milestones to
Phase 2C. §9's phase label is an isolated typo-class error, not a substantive
disagreement about scope — the substance ("Symptom Tracker must never do trend analysis
or AI commentary") is unambiguous and unanimous everywhere else. Recommend a one-word
documentation fix in a future pass; does not block PA-4.

**Finding 2 — docs/33's `*Planned*` labels remain stale for Patient/Patient Identity/
Session (carried forward, not new).** Already named in docs/36 §12 as unresolved after
Identity & Access shipped, and again in docs/39's own Repository Consistency Review
(Finding 2) as still open after PA-3. Unchanged status: these three entities are
long-since implemented (Foundation F3/F4) but docs/33 §1.1/§1.2/§1.3 still read
`*Planned*`. Not a blocker for PA-4 — repeated here only so it is not mistaken for new.

**Finding 3 (new) — docs/33's own Summary Table has drifted from its Timeline Event
section header.** docs/33 §3.1's section header already reads "Timeline Event —
*Implemented (Batch PA-3, one entry_type)*" (correctly updated when PA-3 shipped), but
the document's own Summary Table at the bottom still lists "Timeline Event | Planned |
2A" — an internal inconsistency created by a partial update: the section header was
fixed, the summary row was not. A small, real, easily-fixed drift, not previously
reported — worth folding into the same future documentation pass as Finding 2 rather
than treated as a separate blocker.

**Finding 4 — no new contradiction found between PA-3's actual shipped state and its own
documentation.** Verified directly, not assumed: re-running every committed validation
suite against the current repository state reproduces the exact same results
docs/39/docs/29 §16 already recorded for PA-3 (see Validation Run below) — confirming
zero drift since PA-3's closeout, and that this review's own reading and execution agree.

**Finding 5 — the two committed Playwright browser-test suites could not be executed in
this review's environment.** `validation/pa-2-dashboard/browser-test.js` and
`validation/pa-3-timeline/browser-test.js` both `require('playwright')`, but no
`package.json` exists anywhere in this repository to declare that dependency, and no
`node_modules/playwright` is present in this session. This is a tooling/environment gap
in how the suites are invoked, not a code regression — every Node-only suite
(`static-analysis`, `phase-2a-foundation` conformance, `phase-1-5` regression) ran
cleanly to completion (see below). Stated openly per this repository's own convention of
recording real limitations rather than silently skipping them; does not block this
review's conclusions, since PA-3's backend and its already-recorded frontend results are
independently corroborated by the Node-only suites plus the unchanged, already-reviewed
docs/38/docs/29 §16 closeout notes.

**No duplication found** between this document and docs/37/docs/39/docs/40 — each
reviews a different batch and does not restate another's content; where relevant, this
document cross-references them rather than repeating them.

---

# Validation Run at Time of This Review

Executed directly against the current repository state (branch synced to `origin/main`
at commit `5b395ef`), not assumed from prior documents:

- **Static Analysis** — `node validation/static-analysis/analyze.js` → **PASS, 0
  findings** across duplicate globals, duplicate function names, duplicate constants,
  namespace collisions, unused exported helpers, and circular dependencies (30
  `apps-script/*.gs` files scanned).
- **Conformance** — `node validation/phase-2a-foundation/conformance.js` → **PASS,
  81/81 checks**, covering Foundation, Identity & Access, and PA-3's Consultation
  History stages exactly as documented in docs/39.
- **Regression** — `node validation/phase-1-5/validate.js` → **PASS, 42/42 checks**,
  confirming zero regression to the Phase 1.5 pipeline.
- **Frontend browser suites** — `validation/pa-2-dashboard/browser-test.js` and
  `validation/pa-3-timeline/browser-test.js` could not be run in this environment
  (Finding 5 above — missing `playwright` dependency, no committed `package.json`).
  Not re-verified independently by this review; their last-recorded results
  (26/26 and 29/29 respectively) stand as documented in docs/38 and docs/29 §16,
  unchanged since neither suite's target files were touched by this review.
- **Repository state** — `git status`: clean. Current branch is synced exactly to
  `origin/main` (no divergence in either direction) before this review began.

All three executable suites reproduce the exact counts docs/39 and docs/29 §16 already
recorded for PA-3's shipped state — independent confirmation of zero drift, not a
re-statement of a prior claim.

---

**This review does not authorize Batch PA-4 to begin.** Per this session's explicit
instruction, implementation waits for separate approval — and per §10/§11 above, two
open questions (required/optional field scope, offline behavior) should be explicitly
answered before that approval is given, not inferred silently once implementation
starts.
